Jim Cramer Says Illumina Is 'Challenged,' Recommends Selling This Industrial Stock
Cramer looks at Illumina, Archer Aviation, NANO Nuclear Energy, Steris, Sixth Street Specialty Lending, Lam Research and ...
Illumina price target lowered to $128 from $247 at RBC Capital
RBC Capital lowered the firm’s price target on Illumina (ILMN) to $128 from $247 but keeps an Outperform rating on the shares. The company’s ...
Why Illumina, Inc. (ILMN) Is Plunging So Far In 2025
We recently published an article titled Why These 15 Large-Cap Stocks Are Plunging So Far In 2025. In this article, we are ...
Illumina Unusual Options Activity
Today, Benzinga's options scanner identified 8 options transactions for Illumina. This is an unusual occurrence. The ...
Illumina (ILMN) Gets a Buy from RBC Capital
In a report released yesterday, Conor McNamara from RBC Capital maintained a Buy rating on Illumina (ILMN – Research Report), with a price ...
Zacks.com on MSN1d
JAZZ or ILMN: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Jazz Pharmaceuticals (JAZZ) and Illumina (ILMN). But which of these two stocks is more attractive to value ...
Fierce Biotech4d
Illumina aims to cut $100M in costs following China import ban
Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...
ETF Daily News6d
Jones Financial Companies Lllp Increases Position in Illumina, Inc. (NASDAQ:ILMN)
Hedge funds and other institutional investors own 89.42% of the company’s stock. Several research firms recently commented on ILMN. Morgan Stanley dropped their price objective on Illumina from ...
TD Cowen Sticks to Its Buy Rating for NeoGenomics (NEO)
TD Cowen analyst Daniel Brennan maintained a Buy rating on NeoGenomics (NEO – Research Report) today and set a price target of $19.00. The company’s shares closed yesterday at ...